These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 467630)

  • 1. Psychopharmacological study with K 8409, a 1H-naphtho[2,1-b]pyran 3-dialkylamino substituted derivative.
    Ermili A; Roma G; Buonamici M; Cuttica A; Galante M; Orsini G; Passerini N
    Farmaco Sci; 1979 Jun; 34(6):535-44. PubMed ID: 467630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemical and pharmaceutical research on pyran derivatives. XI. Synthesis of 2-dialkylamino-4-oxo-10-methyl-4H-naphtho[2,3b]pyrans].
    Roma G; Vigevani E; Mazzei M; Ermili A; Ambrosini A; Passerini N
    Farmaco Sci; 1978 Nov; 33(11):822-37. PubMed ID: 744239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride.
    Eguchi J; Inomata Y; Yuasa T; Egawa M; Saito K
    Arzneimittelforschung; 1997 Dec; 47(12):1337-47. PubMed ID: 9450161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemical and pharmacological research on pyran derivatives. VI. 2-Dialkylamino-4-oxo-4H-naphto/1,2-b/pyrans and derivatives].
    Ermili A; Balbi A; Roma G
    Farmaco Sci; 1976 Sep; 31(9):627-48. PubMed ID: 1010035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemical and pharmaceutical research on pyran derivatives. X. Synthesis of 1-oxo-2-alkyl-3-dialkylamino-1H-naphtho[2,1b]pyrans].
    Balbi A; Roma G; Di Braccio M; Ermili A
    Farmaco Sci; 1978 Nov; 33(11):807-21. PubMed ID: 311298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemical and pharmacological research on derivatives of 1H-naphtho/2,1-b/pyran. V. Behavior of some 1-oxo-3-dialkylamino-1H-naphtho/2,1-b/pyrans substituted in the Mannich reaction].
    Ermili A; Mazzei M; Roma G; Ambrosini A; Passerini N
    Farmaco Sci; 1975 Dec; 30(12):1001-16. PubMed ID: 1204827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
    Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
    J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical and pharmacological research on pyran derivatives. VII. Derivatives of naphto/1',2':5,6/pyran/2,3-c/pyrazole and of 12H-naphto/1',2':5,6/pyran/2,3-d/pyrimidine].
    Roma G; Vigevani E; Mazzei M; Ermili A
    Farmaco Sci; 1977 Jan; 32(1):40-53. PubMed ID: 844604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemical and pharmacological research on pyran derivatives. XIV. 3-alkylaminoaphtho/2,1-b/pyran-1-ones and derivatives].
    Balbi A; Di Braccio M; Roma G; Ermili A; Ambrosini A; Passerini N
    Farmaco Sci; 1979 Jul; 34(7):595-611. PubMed ID: 477969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemical and pharmacological research on derivatives of 1H-naphto/2,1-b/pyran. IV. Substituted 1-oxo-3-dialkylamino-1H-naphto/2,1-b/pyrans].
    Ermili A; Mazzei M; Roma G; Cuttica A; Passerini N
    Farmaco Sci; 1975 Nov; 30(11):870-83. PubMed ID: 1193229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemical and pharmacological research on pyran derivatives. XV. Phenyl-substituted 2-(dialkylamino)chromones].
    Balbi A; Roma G; Ermili A; Ambrosini A; Passerini N
    Farmaco Sci; 1982 Sep; 37(9):582-96. PubMed ID: 7128815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PKC activity of some 3-(dialkylamino)-1H-naphtho [2,1-B] pyran-1-ones.
    Mazzei M; Garzoglio R; Sottofattori E; Melloni E; Michetti M
    Farmaco; 1997; 52(8-9):539-45. PubMed ID: 9507662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
    Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological investigations on etoperidone, a new psychotropic agent.
    Lisciani R; Baldini A; de Feo G; Silvestrini B
    Arzneimittelforschung; 1978; 28(3):417-23. PubMed ID: 580751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.